Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide + IFN/RBV for HCV in Type 2 Diabetics
NCT01770483Phase 4Completed
- Sponsor
- Services Institute of Medical Sciences
- Start
- Jul 2011
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nitazoxanide in hepatitis C (HCV), sponsored by Services Institute of Medical Sciences. Started Jul 2011; status: completed.
02
Drugs
nitazoxanide
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01770483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01770483.